AnalystsAndy ChenAndy Chen's Stock Forecasts
AnalystsAndy Chen
Sectors:
Industries:
Analyst Ranking
Top 24%
#1136 out of 4873 analysts
Average Return
+21.95%
Win Rate
29%4 out of 14
Risk vs Reward
Poor
Good
Andy Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | +546.47% | $10.05 | $64.97 | 2023-10-17 - 2024-05-17 | Strong Buy |
Insmed IncINSM | +175.86% | $28.75 | $79.31 | 2024-02-14 - 2025-02-14 | Buy |
Zenas Biopharma IncZBIO | +13.84% | $7.66 | $8.72 | 2025-02-03 - 2025-05-07 | Buy |
Argenx SeARGX | +4.88% | $593.95 | $622.93 | 2024-11-11 - 2025-05-07 | Buy |
Andy Chen Analyst Color
Get additional color on Andy Chen's coverage of popular stocks
Andy Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | 1 | Buy | $21.00 | +188.07% | Upgrades | 17 days ago |
Oruka Therapeutics IncORKA | 1 | Buy | $20.00 | +109.64% | Initiates Coverage On | 3 months ago |
Vera Therapeutics IncVERA | 1 | Buy | $49.00 | +116.62% | Initiates Coverage On | 3 months ago |
Zenas Biopharma IncZBIO | 1 | Buy | $19.00 | +117.89% | Initiates Coverage On | 3 months ago |
Argenx SeARGX | 1 | Buy | $697.00 | +11.89% | Upgrades | 6 months ago |
Celldex Therapeutics IncCLDX | 1 | Buy | $51.00 | +169.70% | Reiterates | 7 months ago |
Kymera Therapeutics IncKYMR | 1 | Buy | $65.00 | +123.29% | Upgrades | 8 months ago |
Roivant Sciences LtdROIV | 1 | Buy | $17.00 | N/A | Initiates Coverage On | a year ago |
Immunovant IncIMVT | 1 | Buy | $55.00 | N/A | Initiates Coverage On | a year ago |
Insmed IncINSM | 1 | Buy | $42.00 | N/A | Initiates Coverage On | a year ago |
Rapt Therapeutics IncRAPT | 2 | Buy | $39.00 | N/A | Initiates Coverage On | a year ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Affimed NvAFMD | 1 | Strong Buy | $60.00 | N/A | Assumes | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.